Catalyst Wire Dossier Catalyst Wire Dossier

JINZHEN

· Lianyungang Kanion Group, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JINZHEN, covering 2024-03-20 to 2024-03-20. Get the full timeline:

Most recent: Clinical Trial Update: JINZHEN for Treatment of Mild to Moderate COVID-19 [Phase 1, Phase 2]

See pricing